MA43925A - Procã‰dã‰s de traitement du virus de l'hã‰patite b - Google Patents
Procã‰dã‰s de traitement du virus de l'hã‰patite bInfo
- Publication number
- MA43925A MA43925A MA043925A MA43925A MA43925A MA 43925 A MA43925 A MA 43925A MA 043925 A MA043925 A MA 043925A MA 43925 A MA43925 A MA 43925A MA 43925 A MA43925 A MA 43925A
- Authority
- MA
- Morocco
- Prior art keywords
- hepatitis
- treatment process
- virus treatment
- virus
- treatment
- Prior art date
Links
- 241000700721 Hepatitis B virus Species 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562147400P | 2015-04-14 | 2015-04-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA43925A true MA43925A (fr) | 2018-12-05 |
Family
ID=55806858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA043925A MA43925A (fr) | 2015-04-14 | 2016-04-13 | Procã‰dã‰s de traitement du virus de l'hã‰patite b |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20160303095A1 (fr) |
| EP (1) | EP3283076A1 (fr) |
| JP (1) | JP2018511621A (fr) |
| AU (1) | AU2016250099A1 (fr) |
| CA (1) | CA2981856A1 (fr) |
| HK (1) | HK1249046A1 (fr) |
| MA (1) | MA43925A (fr) |
| TW (1) | TW201700098A (fr) |
| WO (1) | WO2016168349A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10202105371YA (en) | 2014-12-26 | 2021-07-29 | Univ Emory | N4-hydroxycytidine and derivatives and anti-viral uses related thereto |
| FI3706762T3 (fi) | 2017-12-07 | 2024-12-13 | Univ Emory | N4-hydroksisytidiini ja johdannaisia sekä niihin liittyviä virusten vastaisia käyttötapoja |
| WO2019154261A1 (fr) * | 2018-02-09 | 2019-08-15 | 南京明德新药研发股份有限公司 | Dérivé de pyridine lié à la voie kmd5 |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| CN110057954B (zh) * | 2019-04-30 | 2021-02-23 | 中国医学科学院病原生物学研究所 | 血浆代谢标志物在诊断或监测hbv的应用 |
| JP7237311B2 (ja) * | 2019-06-06 | 2023-03-13 | 京都府公立大学法人 | 化合物、医薬組成物、ｋｄｍ５ｃ阻害剤及び抗うつ剤 |
| US12378201B2 (en) | 2019-06-20 | 2025-08-05 | Board Of Regents, The University Of Texas System | Histone demethylase inhibitors for treating cancers |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010143582A1 (fr) * | 2009-06-11 | 2010-12-16 | 公立大学法人名古屋市立大学 | Dérivés de phénylcyclopropylamine et inhibiteurs de la lsd1 |
| US9186337B2 (en) * | 2010-02-24 | 2015-11-17 | Oryzon Genomics S.A. | Lysine demethylase inhibitors for diseases and disorders associated with Hepadnaviridae |
| JP6113285B2 (ja) * | 2012-09-10 | 2017-04-12 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｂ型肝炎ウイルス感染症の治療及び予防用の６−アミノ酸ヘテロアリールジヒドロピリミジン |
| CN104981458B (zh) * | 2012-10-02 | 2017-07-21 | 吉利德科学公司 | 组蛋白去甲基化酶抑制剂 |
| SG10201707027SA (en) * | 2013-02-27 | 2017-09-28 | Epitherapeutics Aps | Inhibitors of histone demethylases |
-
2016
- 2016-04-13 AU AU2016250099A patent/AU2016250099A1/en not_active Abandoned
- 2016-04-13 JP JP2017553383A patent/JP2018511621A/ja active Pending
- 2016-04-13 HK HK18108874.4A patent/HK1249046A1/zh unknown
- 2016-04-13 WO PCT/US2016/027354 patent/WO2016168349A1/fr not_active Ceased
- 2016-04-13 US US15/098,112 patent/US20160303095A1/en not_active Abandoned
- 2016-04-13 MA MA043925A patent/MA43925A/fr unknown
- 2016-04-13 EP EP16718154.4A patent/EP3283076A1/fr not_active Withdrawn
- 2016-04-13 CA CA2981856A patent/CA2981856A1/fr not_active Abandoned
- 2016-04-14 TW TW105111704A patent/TW201700098A/zh unknown
-
2017
- 2017-08-29 US US15/689,985 patent/US20180042905A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018511621A (ja) | 2018-04-26 |
| TW201700098A (zh) | 2017-01-01 |
| US20180042905A1 (en) | 2018-02-15 |
| US20160303095A1 (en) | 2016-10-20 |
| EP3283076A1 (fr) | 2018-02-21 |
| CA2981856A1 (fr) | 2016-10-20 |
| AU2016250099A1 (en) | 2017-10-12 |
| HK1249046A1 (zh) | 2018-10-26 |
| WO2016168349A1 (fr) | 2016-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280459A (en) | Phosphoramidates for the treatment of hepatitis b virus | |
| ZA201900156B (en) | Phosphoramidates for the treatment of hepatitis b virus | |
| IL282881A (en) | Methods for treating hepatitis b infection | |
| MA52506A (fr) | Procédés de traitement d'infections par des virus nipah | |
| IL264575A (en) | RNA materials for hepatitis b virus infection | |
| EP3360554A4 (fr) | Agent anti-virus de l'hépatite b | |
| EP3370721A4 (fr) | Traitement de l'ostéoarthrite | |
| DK3400291T3 (da) | Manipuleret virus | |
| MA43925A (fr) | Procã‰dã‰s de traitement du virus de l'hã‰patite b | |
| IL245436A0 (en) | New dihydroquinolizinones for the treatment and prevention of hepatitis b virus infection | |
| EP3393506C0 (fr) | Procédé de purification de virus | |
| DK3512863T3 (da) | 2¿-substituerede-N6-substituerede purinnukleotider til behandling af RNA-virus | |
| HRP20251450T1 (hr) | Beta-d-2'-dezoksi-2'alfa-fluoro-2'-beta-c-supstituirani-2-modificirani-n6-supstituirani purinski nukleotidi za liječenje hcv | |
| IL249660A0 (en) | Methods for treating hepatitis b virus and hepatitis d virus infections | |
| EP3375108A4 (fr) | Traitement dewlan | |
| EP3359577A4 (fr) | Hétérodimères e1/e2 du virus de l'hépatite c et leurs procédés de production | |
| EP3370723A4 (fr) | Traitement d'une infection par le virus de l'hépatite delta | |
| DK3137078T3 (da) | Behandling af hepatitis delta-virusinfektion | |
| EP3684342A4 (fr) | Procédé de traitement | |
| EP3317290A4 (fr) | Compositions et méthodes de traitement d'une infection virale | |
| EP3007722A4 (fr) | Méthodes de traitement de l'hypotension | |
| EP3371212A4 (fr) | Peptides et procédé de traitement de l'arrêt cardiaque | |
| FR3017550B1 (fr) | Machine de traitement de dechets infectieux, notamment medicaux | |
| EP3708685A4 (fr) | Procédé de traitement | |
| EP3518911A4 (fr) | Méthodes de traitement du cancer de l'ovaire |